Thyroid Cancer Concerns In rodent studies, GLP-1 drugs increased thyroid C-cell tumors
In perimenopause protocols, microdosing is most commonly applied to growth hormone secretagogues such as Sermorelin or CJC-1295 + Ipamorelin, where starting at the lower end of the dosing range allows the provider to assess individual GH response and tolerance before escalating
While studies have found other health benefits beyond weight loss and better blood sugar levels, the medications effects on mental health have been unclear
Because of the ever-expanding use of GLP-1 receptor agonists, the availability of an oral agent within this therapeutic class has the potential to further increase GLP-1 receptor agonist use and provide an alternative route of administration for patients unable or unwilling to take SC injections
Injectable forms are more direct and often used for higher-demand training periods
Oral therapies matter for four reasons